Characterization of the gut microbiome in HFrEF patients with AF treated with SGLT2i
The structure and function of the gut microbiota in HFrEF patients and HFrEF patients with AF differ from that of healthy people. Even after SGLT2i treatment, their gut microbiota was still different.